Total Payments
$254,424
2024 Payments
$85,559
Companies
37
Transactions
494
Medicare Patients
1,271
Medicare Billing
$134,769
Payment Breakdown by Category
Other$197,538 (77.6%)
Travel$28,722 (11.3%)
Consulting$15,680 (6.2%)
Food & Beverage$8,477 (3.3%)
Research$3,878 (1.5%)
Education$129.61 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $193,358 | 79 | 76.0% |
| Travel and Lodging | $28,722 | 123 | 11.3% |
| Consulting Fee | $15,680 | 10 | 6.2% |
| Food and Beverage | $8,477 | 271 | 3.3% |
| Honoraria | $4,180 | 2 | 1.6% |
| Unspecified | $3,878 | 5 | 1.5% |
| Education | $129.61 | 4 | 0.1% |
Payments by Type
General
$250,547
489 transactions
Research
$3,878
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $98,386 | 126 | $0 (2024) |
| ARGENX US, INC. | $54,886 | 56 | $0 (2024) |
| UCB, Inc. | $51,463 | 66 | $0 (2024) |
| Allergan, Inc. | $33,580 | 117 | $0 (2022) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $5,192 | 14 | $0 (2023) |
| CSL Behring | $4,795 | 6 | $0 (2018) |
| UCB SA | $1,938 | 13 | $0 (2019) |
| Orion Corporation | $1,456 | 2 | $0 (2018) |
| UCB Biosciences Inc. | $1,172 | 9 | $0 (2017) |
| ABBVIE INC. | $430.12 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85,559 | 106 | ARGENX US, INC. ($30,837) |
| 2023 | $40,133 | 61 | UCB, Inc. ($17,804) |
| 2022 | $38,686 | 52 | Alexion Pharmaceuticals, Inc. ($26,083) |
| 2021 | $8,970 | 30 | Allergan, Inc. ($4,979) |
| 2020 | $20,194 | 57 | Alexion Pharmaceuticals, Inc. ($17,325) |
| 2019 | $32,716 | 106 | Alexion Pharmaceuticals, Inc. ($19,935) |
| 2018 | $13,594 | 36 | Allergan Inc. ($7,222) |
| 2017 | $14,573 | 46 | Allergan Inc. ($8,233) |
All Payment Transactions
494 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,812.50 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $76.38 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/09/2024 | UCB, Inc. | Rystiggo (Drug) | Travel and Lodging | In-kind items and services | $1,113.50 | General |
| Category: Neurology | ||||||
| 12/09/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | UCB, Inc. | Rystiggo (Drug) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: Neurology | ||||||
| 12/02/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Neurology | ||||||
| 11/12/2024 | UCB, Inc. | Rystiggo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: Rare Disease | ||||||
| 11/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $132.39 | General |
| Category: Rare Disease | ||||||
| 11/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $10.92 | General |
| Category: Rare Disease | ||||||
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/03/2024 | UCB, Inc. | Zilbrysq (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| Category: Neurology | ||||||
| 10/03/2024 | UCB, Inc. | Zilbrysq (Drug) | Travel and Lodging | Cash or cash equivalent | $18.49 | General |
| Category: Neurology | ||||||
| 10/03/2024 | UCB, Inc. | Zilbrysq (Drug) | Travel and Lodging | Cash or cash equivalent | $3.00 | General |
| Category: Neurology | ||||||
| 09/26/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.47 | General |
| 09/24/2024 | ARGENX US, INC. | VYVGART (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,375.00 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ARGENX US, INC. | VYVGART (Drug) | Travel and Lodging | Cash or cash equivalent | $350.80 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Immunology | ||||||
| 09/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| Category: Neurology | ||||||
| 09/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $107.51 | General |
| Category: Neurology | ||||||
| 09/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,687.50 | General |
| Category: Neurology | ||||||
| 09/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $52.28 | General |
| Category: Neurology | ||||||
| 09/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $33.16 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER, RANDOMIZED, SUBJECT-BLIND, INVESTIGATOR-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY EVALUATING THE EFFICACY, SAFETY, AND TOLERABILI | UCB, Inc. | $3,120 | 1 |
| Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis | Alexion Pharmaceuticals, Inc. | $757.69 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 276 | 440 | $116,456 | $31,290 |
| 2022 | 12 | 326 | 527 | $120,787 | $36,816 |
| 2021 | 11 | 340 | 522 | $113,874 | $37,914 |
| 2020 | 9 | 329 | 487 | $98,564 | $28,750 |
Total Patients
1,271
Total Services
1,976
Medicare Billing
$134,769
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 108 | 183 | $61,691 | $17,973 | 29.1% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 12 | 32 | $11,804 | $3,187 | 27.0% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Facility | 2023 | 11 | 28 | $14,210 | $2,728 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 35 | 40 | $8,624 | $2,438 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $7,460 | $1,987 | 26.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 26 | 65 | $5,724 | $874.02 | 15.3% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 15 | 15 | $2,025 | $724.92 | 35.8% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2023 | 12 | 12 | $1,860 | $551.98 | 29.7% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 27 | 34 | $1,462 | $443.59 | 30.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 13 | 14 | $1,596 | $382.69 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 106 | 195 | $56,328 | $19,808 | 35.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 27 | 27 | $11,844 | $3,528 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 40 | 51 | $10,893 | $3,328 | 30.5% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2022 | 14 | 35 | $7,961 | $3,302 | 41.5% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Facility | 2022 | 11 | 31 | $12,992 | $2,810 | 21.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 31 | 79 | $6,496 | $1,037 | 16.0% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2022 | 17 | 17 | $2,635 | $820.47 | 31.1% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 13 | 13 | $1,755 | $804.95 | 45.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 13 | 15 | $1,710 | $531.38 | 31.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 32 | 41 | $1,763 | $516.45 | 29.3% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 11 | 12 | $5,508 | $265.93 | 4.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 11 | 11 | $902.00 | $64.32 | 7.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 90 | 158 | $44,287 | $17,270 | 39.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2021 | 19 | 43 | $11,590 | $4,567 | 39.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 47 | 58 | $11,693 | $3,728 | 31.9% |
About Dr. Michael Rivner, MD
Dr. Michael Rivner, MD is a Neurology healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669582649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Rivner, MD has received a total of $254,424 in payments from pharmaceutical and medical device companies, with $85,559 received in 2024. These payments were reported across 494 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($193,358).
As a Medicare-enrolled provider, Rivner has provided services to 1,271 Medicare beneficiaries, totaling 1,976 services with total Medicare billing of $134,769. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology
- Location Macon, GA
- Active Since 08/30/2006
- Last Updated 03/18/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1669582649
Products in Payments
- VYVGART (Drug) $41,595
- ULTOMIRIS (Biological) $26,343
- Zilbrysq (Drug) $24,788
- Rystiggo (Drug) $23,419
- BOTOX (Biological) $22,965
- SOLIRIS (Drug) $19,197
- Soliris (Drug) $16,191
- VYVGART HYTRULO (Drug) $13,292
- BOTOX (Drug) $10,306
- SOLIRIS (Biological) $9,791
- Radicava (Drug) $5,164
- Hizentra (Biological) $4,795
- ULTOMIRIS (Drug) $757.69
- BOTOX NEURO REHAB (Drug) $421.43
- Aimovig (Biological) $152.98
- BOTOX THERAPEUTIC (Biological) $148.27
- APTIOM (Drug) $103.09
- UBRELVY (Drug) $77.67
- Gamunex-C (Biological) $77.48
- QULIPTA (Drug) $70.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Macon
Dr. Sudhir Athni, Md, MD
Neurology — Payments: $568,827
Neurology $568,827
Dr. Margaret Boltja, M.d, M.D
Neurology — Payments: $7,455
Neurology $7,455
Dr. Matthew Smith, Md, MD
Neurology — Payments: $5,301
Neurology $5,301
Sourabh Lahoti, Md, MD
Neurology — Payments: $4,456
Neurology $4,456
Dr. Basil Holoyda, M.d, M.D
Neurology — Payments: $3,017
Neurology $3,017
Christina Mayville, M.d, M.D
Neurology — Payments: $2,608
Neurology $2,608